Furthermore, recent studies have shown that TMPRSS2:Erg and EWS-Fli1 fusion proteins also sensitise cancer cells to PARP-1 inhibitors by inducing DNA damage, although these studies did not investigate the accumulation of these proteins [30], [31]. The gene discussed is TMPRSS2; the disease is cancer.